Product Images Gemcitabine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Gemcitabine NDC 0409-0187 by Hospira, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
structural formula gemcitabine - gemcitabine 01
Figure 1: Kaplan-Meier Curve of Progression Free Survival in Gemcitabine Plus Carboplatin Versus Carboplatin in Ovarian Cancer - gemcitabine 02
This is a graph showing the progression-free probability of Gemcitabine/Carboplatin versus Carboplatin alone in a sample of 178 patients. The x-axis shows the progression-free survival in months, while the y-axis shows the probability of remaining progression-free. Gemcitabine/Carboplatin showed a statistically significant benefit compared to Carboplatin alone.*
Figure 2: Kaplan-Meier Curve of Time to Documented Disease Progression in Gemcitabine Plus Paclitaxel Versus Paclitaxel Breast Cancer Study - gemcitabine 03
This is a medical document comparing the progression-free probability and median time to disease progression for two treatments: Gemcitabine / Paclitaxel and Paclitaxel alone. The text includes statistical data such as the number of participants in each treatment group, the log rank p-value and the median time to disease progression in months.*
xen-1822-4Figure 3: Kaplan-Meier Survival Curve in Gemcitabine Plus Cisplatin Versus Cisplatin NSCLC Study - gemcitabine 04
Figure 4: Kaplan-Meier Survival Curve - gemcitabine 05
This seems to be a graph or chart displaying the fraction surviving over a period of time (in months) for two cancer treatments: Gemcitabine and 5-FU. The vertical axis represents the fraction surviving (ranging from 0.0 to 1.0). The horizontal axis shows the survival time in months (ranging from 4 to 20 months). The graph appears to compare the effectiveness of both treatments in treating cancer over time.*
Hospira logo - gemcitabine 06
PRINCIPAL DISPLAY PANEL - 2 g Vial Label - gemcitabine 07
Gemcitabine for Injection, USP is a cytotoxic agent that is available as a 2 g single-dose vial for intravenous use only. The vial is sterile and has an unvarnished area. The product is lyophilized, and caution should be taken when using it. The text also includes various other alphanumeric codes that are difficult to interpret.*
PRINCIPAL DISPLAY PANEL - 2 g Vial Carton - gemcitabine 08
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.